Today in Switzerland: A round-up of the latest news on Wednesday
Find out what's going on in Switzerland today with The Local's short round-up of the news.
Public warned against scams
The National Cyber Security Centre (NCSC) is warning the public about various scams that are circulating in Switzerland or in some of its regions.
They include fake emails, investment fraud, e-banking malware, and other schemes. Some may sound plausible but all are seeking to extort money from unsuspecting individuals.
The Local will publish an article today outlining the latest scams and NCSB’s advice on how to avoid falling victim to these unscrupulous schemes.
Vaud doctors to begin vaccinating patients against Covid
Along with general practitioners in Zug, who started to inoculate their patients against coronavirus on Tuesday, physicians in Vaud are beginning to administer vaccines in their offices from today.
The first to receive their shots will be 10,400 patients who are over 75 and at risk from chronic illnesses.
For the time being, vaccination will be limited to 250 practices due to the limited number of doses available.
General practitioners in other cantons are expected to start vaccinating their patients in the near future.
Gale-force winds expected in Switzerland this week
Spring season is not quite here yet, meteorologists say.
From Thursday, wind gusts of up to 100 km / h are expected to sweep Switzerland and temperatures will drop before the weekend.
"In the lowlands there will be gusts of 60 to 90 kilometres per hour and in the mountains over 100 kilometres per hour," said Stefan Scherrer from MeteoNews weather service.
The winds will be followed by a cold front, he said.
Switzerland develops medicine to treat Covid-19
The Zurich laboratory Molecular Partners claims a milestone in the development of its experimental treatment against coronavirus.
Initial findings indicate that the drug, Ensovibep, is safe and well tolerated with no significant adverse events”, the manufacturers reported.
The antiviral treatment is still in its clinical trial phase, with further tests planned scheduled in the spring.
In August, Swiss authorities signed a ‘reservation agreement’ for the delivery of 200,000 doses of this medication.
If it successfully passes clinical trials and is approved for the market, Switzerland will receive priority access.
Swiss employers won’t ask workforce to get vaccinated
Only 1 percent of Swiss employers intend to ask that their employees get a coronavirus shot, according to a survey by Manpower Group.
This is the lowest rate in the world — globally, 16 percent of respondents believe their employees should be vaccinated.
However, 41 percent of Swiss employers said they plan to encourage vaccination by highlighting its benefits.
If you have any questions about life in Switzerland, ideas for articles or news tips for The Local please get in touch with us at [email protected]